Detalhe da pesquisa
1.
Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial.
Gynecol Oncol;
182: 7-14, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38246047
2.
Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045.
Int J Cancer;
153(12): 2032-2044, 2023 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37602928
3.
Characterization of early postzygotic somatic mutations through multi-organ analysis.
J Hum Genet;
66(8): 777-784, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33611337
4.
EHMT2 Inhibition Induces Cell Death in Human Non-Small Cell Lung Cancer by Altering the Cholesterol Biosynthesis Pathway.
Int J Mol Sci;
21(3)2020 Feb 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32028644
5.
Reply to: Comments on "Randomized, two-arm, non-comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045".
Int J Cancer;
154(4): 764-765, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37907776
6.
Promotion of Cell Death in Cisplatin-Resistant Ovarian Cancer Cells through KDM1B-DCLRE1B Modulation.
Int J Mol Sci;
20(10)2019 May 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31108893
7.
Comparison of the Antioxidant Potency of Four Triterpenes of Centella asiatica against Oxidative Stress.
Antioxidants (Basel);
13(4)2024 Apr 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38671930
8.
Single-Cell Profiling Reveals Immune-Based Mechanisms Underlying Tumor Radiosensitization by a Novel Mn Porphyrin Clinical Candidate, MnTnBuOE-2-PyP5+ (BMX-001).
Antioxidants (Basel);
13(4)2024 Apr 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38671924
9.
Comprehensive profiling of DNA methylation in Korean patients with colorectal cancer.
BMB Rep;
57(2): 110-115, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37605617
10.
Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer.
Cancer Res Treat;
55(1): 219-230, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35410113
11.
Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer.
Cell Discov;
9(1): 114, 2023 Nov 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37968259
12.
A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17-11).
Clin Cancer Res;
28(19): 4240-4247, 2022 10 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35819451
13.
Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC.
Clin Cancer Res;
28(19): 4312-4321, 2022 10 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35838647
14.
Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data.
Cancers (Basel);
13(10)2021 May 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34069252
15.
Photomodulating Carbon Dots for Spatiotemporal Suppression of Alzheimer's ß-Amyloid Aggregation.
ACS Nano;
14(12): 16973-16983, 2020 Dec 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33236883
16.
Genetic Alterations Detected by Targeted Next-generation Sequencing and Their Clinical Implications in Neuroblastoma.
Anticancer Res;
40(12): 7057-7065, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33288603
17.
Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone.
Nat Commun;
11(1): 5414, 2020 10 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33110075
18.
Clinicopathologic and Molecular Subtyping of EGFR Mutation-Response.
Clin Cancer Res;
29(3): 687, 2023 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36722137
19.
Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3.
Sci Data;
5: 180283, 2018 12 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30532024
20.
Annual Reproductive Cycle of Acheilognathus majusculus, a Korean Endemic Species.
Dev Reprod;
21(3): 297-305, 2017 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29082345